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Inflammasomes are multiprotein complexes present in the cytosol as pattern recognition 
receptors or as sensors of damage-associated molecular patterns. After recognition 
of microbe-associated molecular patterns or host-derived danger signals, nucleotide 
oligomerization domain-like receptors oligomerize to form inflammasomes. The activa-
tion of inflammasomes results in an alarm, which is raised to alert adjacent cells through 
the processing and release of a number of other substrates present in the cytosol. 
A wide array of inflammasomes and their adapter molecules have been identified in 
the host’s innate immune system in response to various pathogens. Components of 
specific pathogens activate different inflammasomes, which once activated in response 
to pathogen-induced infection, induce the activation of caspases, and the release of 
mature forms of interleukin-1β (IL-1β) and IL-18. Identifying the mechanisms underlying 
pathogen-induced inflammasome activation is important if we are to develop novel ther-
apeutic strategies to target sexually transmitted infections (STIs) related pathogens. This 
information is currently lacking in literature. In this review, we have discussed the role of 
various inflammasomes in sensing different STIs, as well as the beneficial or detrimental 
effects of inflammasome signaling in host resistance. Additionally, we have discussed 
both canonical and non-canonical processing of IL-1β induced with respect to particular 
infections. Overall, these findings transform our understanding of both the basic biology 
and clinical relevance of inflammasomes.
Keywords: innate immunity, inflammasomes, NOD-like receptors, sexually transmitted infections, host defense, 
pathogens
iNTRODUCTiON
Innate immune receptors act as the first line of defense against infectious microbes, continuously 
monitoring the extracellular milieu as well as subcellular compartments. These receptors can 
either be extracellular, such as some of the toll-like receptors (TLR) and C-type lectin receptors 
(CLR), or intracellular, such as nucleotide oligomerization domain (NOD)-like receptors (NLR), 
retinoic-acid-inducible gene (RIG-I)-like receptors (RLR), and AIM2 (absent in melanoma 2)-like 
receptors (ALR). Cytosolic immune receptors not only act as pattern recognition receptors (PRRs) 
that recognize pathogen-associated molecular patterns (PAMPs) but also sense signals derived 
from the host commonly known as damage-associated molecular patterns (DAMPs). These include 
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intracellular molecules such as ATP and high-mobility group box 
1 (HMGB1) protein as well as proteins derived from extracellular 
matrix. These PRRs trigger a downstream signaling cascade in 
the presence of specific ligands, resulting in the activation of 
transcription machinery inducing the production and release of 
pro-inflammatory cytokines. These cytokines further regulate the 
switch between tissue homeostasis and the inflammatory state, 
aimed at the removal of pathogens thus restoring normal tissue 
function (1).
Inflammasomes are multiprotein complexes consisting mainly 
of NLR, ASC (apoptosis-associated speck-like protein), and 
caspase-1, which are formed upon activation by specific ligands. 
NLRs are cytosolic protein receptors, and under highly regulated 
conditions, they assemble with ASC and caspase-1 to form 
speck-like aggregates (2, 3). The composition of inflammasomes 
varies in response to different ligands, for example, NLRP1 is a 
sensor of muramyl dipeptide (MDP: toxin of Bacillus anthracis) 
(4), NLRP3 responds to various cytosolic insults such as reactive 
oxygen species (ROS) (5), cathepsin B release (6), pore forming 
toxins [PFTs: nigericin (7)], extracellular crystals (8), and NLRC4 
that oligomerizes in response to the presence of flagellin and PrgJ 
rod proteins within the cytoplasm (9). PYHIN (pyrin containing 
HIN200 domain) containing AIM2 and IFI16 (interferon-γ-
inducible protein 16) initiates the formation of the inflammasome 
in response to foreign cytoplasmic double-stranded DNA (10, 
11). Initially suggested as sensors of a microbial infection (12), 
inflammasomes have recently emerged as central orchestrators 
of microbial infections (13).
Aberrantly high inflammasome activation and abrogation 
of inflammasome signaling in different tissues leads to the 
development of various inflammatory pathologies, indicating 
the necessity of a finely balanced signaling cascade and a down-
stream cytokine release. Initial regulation of inflammasome 
activity occurs through transcriptional/posttranslational control. 
As a consequence of this, inflammasome expression levels are 
usually low in most cell types at the steady state. A stimulus (for 
example, extracellular PRR signaling) is required for induction 
of the inflammasome gene transcription and is known as signal 
1 or priming (14, 15). Inflammasome formation then depends 
on the activation of specific NLR triggers, referred to as signal 2. 
Many potential inflammasome stimulators are now known, such 
as microbe-derived substances, molecules related to endogenous 
damage, and environmental particles (16).
Inflammasomes recruit and activate pro-inflammatory cas-
pases, which result in the cleavage of pro-forms of IL-1β and IL-18 
into mature and secretable forms. Each inflammasome contains 
ASC, an adaptor protein for caspase activation and a recruitment 
domain (CARD); however, NLRC4 contains a CARD domain 
that itself interact with caspase-1. Furthermore, inflammasome 
activity is tightly regulated since it leads to the production of 
some of the most potent pro-inflammatory cytokines (IL-1β 
and IL-18) and the subsequent induction of inflammatory cell 
death, pyroptosis (12). Inflammasome-mediated processes act as 
a key factor for clearance of infections and regulation of various 
metabolic and immune processes. In the past decade, inflamma-
some research has intensified with regards to various metabolic 
and infectious diseases. However, the mechanisms behind the 
stimulus of inflammasome assembly during sexually transmitted 
infections (STIs) are poorly understood.
Sexually transmitted infections are one of the most highly 
prevalent infections, with 340 million new cases every year 
worldwide, of which 50% are among adolescents and young 
adults (17). Most of these STI cases are reported in developing 
nations, mainly South Asia, Southeast Asia, Sub-Saharan Africa, 
Latin America, and the Caribbean (18). STIs impose huge 
economic losses every year because of its high incidence (19). 
STDs cost the U.S. health-care system an amount of $15.9 billion 
annually (20). Though STIs caused by bacterial, mycological, and 
protozoan agents can be treated successfully, all the viral STIs 
are not treatable with current medications. STIs not only cause 
intense morbidity in adults but also lead to intense complications 
such as infertility, ectopic pregnancy, fetal wastage, premature 
birth, low birth weight, premature mortality, cervical tumor, 
inborn syphilis, and ophthalmia neonatorum (21). The effect 
of inflammasome signaling during the development of various 
STIs has not been adequately studied. Here, we review the recent 
progress of our understanding of inflammasome signaling and 
the consequences of defective inflammasome activation during 
various STIs.
CHLAMYDIA iNFeCTiON
Chlamydia trachomatis, an obligate intracellular Gram-negative 
human pathogen, is a leading cause of bacterial STI and prevent-
able blindness worldwide. C. trachomatis infects both men and 
women and inflicts a wide range of diseases including conjuncti-
vitis, urethritis, ectopic pregnancy, and infertility in the affected 
women. Infection of pregnant women can be passed on to the 
baby during pregnancy or childbirth, causing conjunctivitis or 
fatal pneumonia in the newborn. Chlamydia affects 90 million 
new cases each year worldwide (22).
The pathogenesis of the Chlamydia infection and the result-
ing inflammatory process have been examined using multiple 
animal models and in vitro studies (22). The infection is initiated 
by the attachment and entry of elementary bodies (EBs) into 
epithelial cells that transit into replicative reticulate bodies (RBs) 
to establish a parasitophorous vacuole, also known as inclusion 
(23). C. trachomatis employs a type III secretion system (T3SS) 
and encodes a chlamydial protease-like activity factor (CPAF) to 
establish a replicative niche within host cells (24, 25). Response 
to an epithelial cell infection occurs within a few days and is char-
acterized by neutrophil infiltration, which kills accessible EBs, 
followed by an accumulation of T-cells and other leukocytes in 
the infected area (26). The inflammatory process resulting from 
primary infection often results in either long-term tissue damage 
or tubal damage and infertility (22).
Chlamydia trachomatis activates the NLRP3 inflammasome 
in an ASC and caspase-1-dependent manner in diverse human 
and mouse cells (27–30). However, the role of non-NLRP3 
inflammasomes during infection cannot be totally refuted. In a 
recent animal study, a murine model of Chlamydia muridarum 
infection shows interferon (IFN)-inducible guanylate-binding 
protein (GBP)-dependent pyroptosis through activation of cas-
pase-11-dependent non-cannonical and caspase-1-dependent 
TABLe 1 | Different inflammasomes activated during STis and their respective stimulus.
S. no. Organism/disease inflammasome 
activated
Ligands and activation stimulus experimental 
model
Reference
1 Chlamydia 
trachomatis
NLRP3, NOD 1 Type third secretion system (T3SS), chlamydial protease-likeactivity factor 
(CPAF)
Monocytes, dendritic 
cells
(27–30)
2 Candida albicans: 
candidiasis
NLRP3, NLRC4 Hyphae formation induces IL-1β secretion, syk signaling activates NLRP3 
through CARD9, C. albicans infection activated NLRC4 in mucosal 
stromal cells
Monocytes-derived 
macrophages and 
dendritic cells
(42–44)
3 HIV: AIDS NLRP3 Pro IL-1β expression occurs through TLR8-dependent mechanism 
and IL-1β processing is done by NLRP3 activation, which occurred by 
HIV-1-induced ROS generation and cathepsin B release from disrupted 
lysosomes
Thp1-derived 
macrophages and 
peripheral blood 
mononuclear cells
(45)
4 Herpes simplex virus: 
genital herpes
IFI16 (AIM2-like 
receptors)
Cytosolic DNA sensed by IFI16 Thp1-derived 
macrophages
(11)
5 Human papilloma 
virus
IFI16 and AIM2, 
NLRP3
IFI16 and AIM2 sense viral DNA present in cytosol, Cathepsin B release 
and ROS generation activates NLRP3
Keratinocytes, Thp1 
cells
(46, 47)
6 Haemophilus ducreyi: 
chancroid
AIM2 and NLRP3 ROS generation, K+ efflux, Cathepsin B activity, and lysosome acidification MDM, Thp1-cells (48)
7 Neisseria gonorrhoea: 
gonorrhea
NLRP3 N. gonorrhoea activates Cathepsin B which is responsible for NLRP3 Thp1, PBMC-derived 
macrophages
(49)
8 Treponema pallidum: 
syphilis
– Activation by extracellular ATP followed by binding to P2Ξ7 receptor PBMC-derived 
macrophages
(50)
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cannonical inflammasomes (NLRP3 and AIM2) (31). In 
NLRP3−/−- and ASC−/−-deficient mice, survival of Chlamydia 
and caspase-1-dependent IL-18 secretion (32) were reduced, 
and lipid droplets were accumulated showing evidence of 
promotion of atherosclerosis and metabolic diseases (33). 
In another study, ApoE−/− (Apolipoprotein E)-deficient mice 
fed on high fat diet and infected with Chlamydia resulted in 
accelerated atherosclerosis with a presence of activated myeloid 
DCs (mDCs) and plasmacytoid DCs (pDCs) (34). In a report 
from Nagarajan et al., mice deficient in IL-1R showed delayed 
clearance of Chlamydia, supporting the role of IL-1β in infection 
clearance, but they suggested a low significance of inflamma-
some pathways in IL-1β secretion and genital tract pathologies 
(32). Particularly pORF5, a secretory protein of Chlamydia sp. 
has been found to facilitate the secretion of IL-1β and IL-18 
through NALP3 activation (35).
In mouse bone marrow macrophages, the AIM2 inflamma-
some contributes partially to the production of IL-1β and IL-18 
during the infection (31). Thus, prior exposure of C. trachomatis-
infected THP-1 cells to anti-oxidants partially inhibits IL-1β 
secretion, reinforcing the fact that multiple upstream mecha-
nisms or inflammasomes may be involved (30). Thus, multiple 
pathways including non-TLRs contribute to IL-1β production 
equally. Evidence suggests a role of NOD1 in IL-1β secretion from 
a human trophoblast cell line exposed to Chlamydia (36).
Contrary to the protective function of the NLRP3 upon infec-
tion with the respiratory pathogen Chlamydia pneumoniae (37), 
caspase-1 activation promotes the growth of C. trachomatis in 
cervical epithelial cells (29). The finding mentioned in the former 
study is supported at least partially by the observed inflammasome-
mediated pyroptosis of Chlamydia-exposed antigen presentation 
cells, which are critical in Chlamydia clearance (38). However, a 
later study has its own limitations as the results were obtained in 
IL-10−/− dendritic cells (DCs) and no direct observations were 
made in cells lacking inflammasome components. Nevertheless, 
IL-10 deficiency does result in enhanced inflammasome activa-
tion (39, 40). Contrary to the results in cervical epithelial cells, 
Caspase-1−/− mice exhibit similar C. trachomatis growth in the 
urogenital tracts (41). However, a Caspase-1 deficiency results 
in significantly reduced inflammatory damage, suggesting that 
inflammasomes may not be directly controlling the C. trachoma-
tis infection in vivo per se, but caspase-1 activation can invoke the 
Chlamydia-induced inflammatory pathologies in the genital tract 
(41) (Table 1; Figure 1).
Candidiasis
Candidiasis is a well-known fungal infection caused by the yeast 
Candida with more than 20 different types known so far. Candida 
albicans is a well-tolerated resident of mucosal surfaces of the 
gastrointestinal and urogenital tract in most healthy people. 
However, an overgrowth of C. albicans can lead to an invasion 
of the epithelium causing oropharyngeal candidiasis (thrush) 
or genital/vulvovaginal candidiasis (yeast infection). The “yeast 
infection” is so common that nearly 75% of all adult women have at 
least one infection in their lifetime. Additionally, during primary 
and/or secondary immunodeficiency, yeast is the primary cause 
of opportunistic infections causing mucocutaneous candidiasis 
and occasionally systemic sepsis (51).
The cell wall architecture of Candida is well characterized and 
is deemed essential for the biology and pathogenicity of C. albi-
cans (52). It consists of three basic constituents: β-glucans, chitin, 
and mannoproteins. β-glucans and chitin represent the structural 
components and provide physical properties to the cell wall (52). 
β-glucans and mannans display the most potent immunomodu-
latory activity leading to NLRP3 inflammasome activation and 
IL-1β secretion in mouse macrophages and human monocytes 
(53). The transcriptional upregulation of IL-1β is attained by 
FiGURe 1 | Model: inflammasome activation and pro-inflammatory cytokine release during various STis. Synchronization of various inflammasomes and 
their adapters in the regulation of pro-inflammatory cytokine release. Cytosolic DNA and viral RNA of various viruses (HIV, HSV-2, and HPV) and different pathogens 
are sensed by AIM2 inflammasome. PAMPs and DAMPs of Haemophilus ducreyi, Neisseria gonorrhoeae, and TPF1 (Treponema pallidum factor-1) of Treponema 
pallidum trigger NLRP3 inflammasome. CPAF protease of Chlamydia trachomatis inhibits NF-κB signaling and pathogen triggers NLRP3 signaling via Nod 1 adapter. 
IL-1β release resulting from Candida albicans infection is mediated by caspase-8 activation. Abbreviations: NLRP, Nod-like receptor protein; NLRC4, Nod-like 
receptor containing CARD4; AIM2, absent in melanoma 2; IFI16, interferon inducible; LPS, lipopolysaccharide; MDP, muramyl dipeptide; PFTs, pore forming toxins; 
ROS, reactive oxygen species.
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Dectin-1, TLR2, and mannose receptor signaling upon recogni-
tion of specific Candida cell wall components, known as signal 1 in 
case of candidiasis (54). Inflammasome-mediated IL-1β secretion 
is essential in mounting a protective Th17 response that is central 
for the activation of mucosal antifungal immunity (55–57). In 
agreement, mice inept at sensing C. albicans demonstrate an 
enhanced dissemination of a mucosal infection and significant 
mortality in vivo (58). Activation of the NLRP3 inflammasome 
is mediated by a two-signal mechanism. However, the tyrosine 
kinase syk, functioning downstream of Dectin-1, couples both 
the two signals during a C. albicans infection. The syk/CARD9 
pathway upregulates IL-1β production (59, 60), while syk-
mediated ROS production and potassium efflux enable caspase-1 
and inflammasome activation, resulting in IL-1β maturation (53). 
These studies suggest that syk and NLRP3 are critical in control-
ling C. albicans infection. Mice lacking either syk or NLRP3 
demonstrate an enhanced fungal burden and mortality (53, 61). 
Furthermore, targeted deletion studies suggest a key importance 
of syk in CD11c+ cells during systemic candidiasis (61) implying 
that NLRP3 activation in CD11c+ cells governs candidiasis.
Ligation of dectin-1 with specific antigens assembles inflam-
masomes independent of caspase-1. Exposure of DCs to curdlan 
and certain C. albicans strains assembles the Dectin-1 triggered 
CARD-9–Bcl-10–MALT1 scaffold for IL-1β transcription. At the 
same time, Dectin-1 initiates recruitment of MALT1–caspase-8 
and ASC into this scaffold leading to caspase-8 (56)-dependent 
pro-IL-1β cleavage. This suggests that distinct downstream sign-
aling pathways can possibly also be triggered through the same 
receptor suggesting the diversity of immune pathways and their 
activation mechanisms. It is likely that the affinity of receptor–
ligand interactions dictates these discrete signaling outcomes. 
Contrary to the previous belief, the caspase-8/NLRP3 inflamma-
some can be initiated independent of pathogen internalization. 
However, activation of NLRP3 is ambiguous in this setting, and it 
is possible that either fungi or their secreted toxins progress to the 
cytoplasm. The emergences of non-canonical and non-redundant 
inflammasomes for pro-IL-1β processing emphasize the diversity 
and versatility of the immune response to pathogens (56).
The precursor form of IL-1β can be cleaved by several 
proteases; however, it is still surprising that CARD-containing 
caspase-8 can substitute for caspase-1 in the inflammasome 
considering that no other caspase family member is known to 
do so (62). Secreted aspartic proteases (Sap), a family of extracel-
lular proteases released by Candida, also triggers IL-1β and IL-18 
maturation dependent on K+ efflux and ROS production (44). 
Particularly, Sap 4–6 proteases activate NLRP3-triggered IL-1β 
secretion in vaginal fluid and recruit polymorphonuclear neu-
trophils (PMNs) during C. albicans intravaginal challenge (63). 
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On the other hand, endocytosis of Sap stimulates the caspase-11 
inflammasome through type I IFN signaling (64). Thus, Sap 
proteins serve as trigger factors for both canonical and non-
canonical inflammasomes.
Dimorphic Candida switches from the yeast form (blastoco-
nidia) to filamentous forms (hyphae) during decreased oxygen 
tension or limiting nutrients (65). Filamentous hyphal forms 
of Candida are considered virulent since they facilitate adhe-
sion and penetration of epithelial and endothelial cells (65). 
The hyphal form has also been suggested to be essential for the 
activation of the NLRP3 inflammasome (42). However, whether 
this is sufficient enough is not clear since certain morphologically 
similar mutants induce lower levels of IL-1β than wild-type C. 
albicans. More importantly, certain mutants defective in hyphae 
formation trigger comparable levels of IL-1β secretion, thus 
implying that other microbial and host mechanisms are more 
likely to contribute to activating inflammasome assembly (66). 
In a murine model of oropharayngeal candidiasis, NLRP3 in 
either the hematopoietic/stromal compartments and epithelial 
NLRC4 play an important role in immune resistance to Candida, 
by mounting pro-inflammatory and antimicrobial responses 
(43). However, whether this is indeed true during intravaginal 
challenge is still not clear. It has been argued that recurrent epi-
sodes of symptomatic infection in women, which are associated 
with immune hyperreactivity to the fungus lead to exaggerated 
pathological inflammation and a robust vaginal PMN migration. 
This is driven by NLRP3 and epithelial NLRC4 activity, which 
is important during vaginal challenge and ineffective inflam-
mation. A robust vaginal PMN migration occurs in susceptible 
women, promoting pathological inflammation without affecting 
fungal burden due to NLRP3 activation (67). Thus, during a 
vaginal challenge, both NLRP3 and NLRC4 were activated. While 
NLRP3 contributes to neutrophil recruitment and pathogenic 
inflammation, IL-22-induced pNLRC4 restricts NLRP3 by a 
sustained production of IL-1Ra (67). This suggests that while 
NLRP3 activity is critical in controlling systemic dissemination 
of the infection, NLRC4 activity in stromal cells is required for the 
protection from mucosal candidiasis (Table 1; Figure 1).
Human immunodeficiency virus
Human immunodeficiency virus (HIV) is a retrovirus (ssRNA 
virus) that causes persistent inflammation and acute immune 
activation, which is a primary characteristic of this disease that 
contributes to the development of acquired immune deficiency 
syndrome (AIDS) (68, 69). The virus causes an infection with 
the transfer of body fluids from an infected person to another, 
which includes semen, vaginal fluids, breast milk, and blood. 
In its new host, the virus uses the envelope glycoprotein gp120 
to attach to a CD4 receptor found on T-cells, monocytes, and 
macrophages. Around 35 million individuals are infected with 
HIV worldwide (70).
Polymorphisms in genes encoding NLRP3 and IL-1β have 
been observed in susceptible patients (71). However, the tran-
scriptional profile of genes encoding inflammasome components 
in HIV patients is still under debate. HIV-positive patients dis-
play a similar transcriptional expression of inflammasome genes 
in peripheral blood mononuclear cells (PBMCs) compared with 
controls (72). However, ex vivo studies show that DCs obtained 
from HIV-1 patients are unresponsive as compared to an elevated 
mRNA expression of NLRP3, caspase-1, and IL-1β in control DCs 
(73). Having said that patient DCs possess an enhanced basal 
expression of NLRP3 and the unresponsiveness to a subsequent 
infection might be due to the saturation in NLRP3 gene levels or 
due to a chronic inflammatory state of these cells (73).
In monocytes and macrophages, HIV-1 is sensed by TLR8 lead-
ing to inflammasome activation, and this is not accompanied by 
type I IFN production (45, 74). This is an infection-independent 
mechanism and reveals utilization of distinct TLRs by different 
cell types for type I IFN or inflammasome pathways of inflam-
mation. Interestingly, HIV-1 replication steps including entry, 
reverse transcription and integration, but not virion maturation, 
were all required, and HIV-1-induced ROS and cathepsin B also 
were necessary for the activation of NLRP3 inflammasome (45). 
The primary cause for progression to AIDS is the progressive loss 
of CD4 T cells, which might be due to inflammasome-induced 
pyroptosis, an inflammatory form of programed cell death (75). 
Cell-to-cell transmission of HIV is required for activation of 
caspase-1-dependent pyroptosis, and cell-free HIV-1 virions fail 
to induce pyroptosis (76) (Table 1; Figure 1).
Genital Herpes
A crucial viral disease caused by herpes simplex virus type 1 
(HSV-1) and type 2 (HSV-2) is known as genital herpes. Oral 
herpes is the most common form of this disease with visibly clear 
symptoms such as facial or oral infections and cold sores. Genital 
herpes is the second most common form of herpes infection 
(77). The specific clinical characteristics of herpes infections are 
painful ano-genital ulceration. HSV-1 and HSV-2 are the cause 
of oro-labial ulcers and ulcerative lesions, respectively, in adult 
populations (77). HSV-1-infected cells mediate the induction of 
IFN in which IFI16 and the murine protein p204 play an indis-
pensable role (11). During HSV-2 infection, STING activates 
the NF-κB pathway (signal 1) to produce pro IL-1β through 
RIP1 and RIP3 (receptor-interacting protein). The viral DNA is 
sensed by the IFI16 inflammasome (signal 2), which oligomer-
izes to activate caspase-1 to convert pro-IL-1β into mature IL-1β  
(Table 1; Figure 1).
Human Papilloma viruses
The human papilloma viruses (HPVs) are non-enveloped, double-
stranded DNA viruses that are the principle cause of benign warts 
and infections of the ano-genital region. Recent advancements in 
HPV-associated research led to the discovery of approximately 
180 types of HPVs (78). The most common HPVs such as HPV-6 
and HPV-11 constitute a 100% protective quadrivalent vaccine 
agent against genital warts infection (79).
A human papilloma virus activates the AIM2 inflammasome 
through viral DNA recognition. Additionally, another DNA sen-
sor, IFI6, is activated resulting in IFN-γ release. The presence of 
the two DNA sensors and the active forms of caspase-1 and IL-1β 
are detectable in HPV-positive skin lesions, in which the virus 
selectively infects keratinocytes in stratified epithelia. However, 
the two DNA sensors seem to negate the effect of the other as 
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blocking one of the sensors potentiates responses from the other 
in experiments performed in normal human keratinocytes (46). 
Whether and what role HPV does play in these processes is 
unclear from the current studies and a detailed understanding 
of these molecular pathways is required to develop improved 
strategies for the prevention and treatment of HPV infections 
(Table 1; Figure 1).
Chancroid
Haemophilus ducreyi (Gram-negative, cocci) is a causative agent 
of the genital ulcer disease known as chancroid. The disease is 
prevalent in certain underdeveloped regions of Africa, Asia, and 
the Caribbean. Infection levels are very low in the developed 
countries and are mainly reported among individuals who have 
traveled outside these countries to affected regions.
Haemophilus ducreyi infection activates the inflammasome 
in monocyte-derived macrophages and experimentally infected 
human skin (48). Secretion of NLRP3-dependent IL-1β in mac-
rophages is dependent on both caspase-1 and caspase-5. However, 
these results have been observed with caspase-1 and caspase-5 
inhibitors, and further studies using genetic knockdown tools 
are required to substantiate this data. Interestingly, this activa-
tion is limited to M1 and M2 macrophages while non-polarized 
macrophages fail to activate inflammasomes, suggesting that the 
precise contribution of inflammasomes in human lesions cannot 
be directly extrapolated (48) (Table 1; Figure 1).
Gonorrhea
Neisseria gonorrhoeae is a Gram-negative diplococcus that can 
grow and rapidly multiply in the mucous membranes especially 
in the mouth, throat, anus, cervix, fallopian tubes, and uterus of 
the infected individuals. Gonorrhea represents an estimated 60 
million cases of urethritis and cervicitis every year around the 
world (80).
Even before inflammasome was first characterized, distinct 
immortalized epithelial cell lines from human endocervix, 
ectovervix, and vagina were demonstrated to secrete IL-1β and 
other pro-inflammatory cytokines when exposed to piliated 
N.  gonorrhoeae (81, 82). Later studies revealed the identity of 
the NLRP3 inflammasome involved in causing pyronecrosis and 
HMGB1 release in macrophages in a cathepsin B-dependent man-
ner. Hexa-acylated lipid A lipooligosaccharide, a N.  gonorrhoeae 
virulence factor, activates the NLRP3 inflammasome (83). 
However, the phagosomal disruption and penetrance of host 
cytosol by N. gonorrhoeae as possibly activating NLRP3 cannot 
be completely ruled out (49) (Table 1; Figure 1).
Syphilis
Treponema pallidum, a spirochete bacterium causing syphilis, 
is a well-known STI. Despite the fact that the essential course 
of transmission is through sexual activities, it is also transmit-
ted to the fetus from mother either during pregnancy or at the 
time of childbirth, thus increasing chances of induced congenital 
syphilis. Protease resistant antigen T. pallidum factor-1 (AgTpF1) 
is found to be involved in the stimulation of monocytes resulting 
in the release of pro-inflammatory cytokines such as TNF-α, IL-6, 
and IL-1β. The IL-1β release was found to be particularly due 
to the inflammasome activation at early stages of syphilis infec-
tion (50). In a syphilis infection, Bacterioferritin protein TpF1 
of T. pallidum activates the NLRP3 inflammasome to mediate 
the cleavage of pro IL-1β/18 into a mature and bioactive form of 
IL-1β/18 (Table 1; Figure 1).
Urinary Tract infection
Urinary tract infections (UTIs) are mostly caused by uropatho-
genic Escherichia coli (UPEC). UTIs affect at least 60% of all 
women once in their lifetime. UPEC virulence includes proteins 
that function in immune evasion, fimbriae, toxins, iron uptake, 
and biofilms. Innate immune responses are induced by neutro-
phils, antimicrobial peptides, and PRRs such as NLRs.
Despite several studies of the function of TLRs in UTI, the 
role of NLRs in UTI has not been elucidated. One of the few 
studies in the murine model of cyclophosphamide (CP) induced 
cystitis, glyburide suggested to suppress caspase-1 with reduction 
in the release of IL-1β; whereas NLRP3 inhibition blocks bladder 
dysfunction in CP model (84). The coordinated response of NLRs 
and TLRs in the urothelia represented a first line of innate defense. 
Another study identified a protective role of autophagy gene 
ATG16L1 deficiency in UPEC-induced UTIs (85) and inflam-
masome activation is known to inhibit autophagy by regulating 
the secretion of IL-1β. NOD2 was found to be dispensable in the 
pathogenesis of UTIs in mice as well. Species and strain-specific 
inflammasome activation was found to be partially dependent 
on NLRP3 in human macrophages and completely in mouse 
macrophages (86).
CONCLUSiON AND FUTURe 
PeRSPeCTiveS
While our understanding of inflammasomes and their various 
regulatory mechanisms has increased tremendously in the last 
decade, we have only scratched the surface in terms of inflamma-
some activation during urinary and STIs. UTI-causing species 
belonging to genus Enterococcus, Klebsiella, and Staphylococcus 
induce NLRP3 inflammasome activation leading to excessive 
secretion of IL-1β and cell death in macrophages (87–91). 
However, the role of inflammasomes and the mechanism behind 
their activation are still unknown, due to the limited knowledge 
in this field. This is partly due to the lack of appropriate animal 
models available to study UTIs and STIs. However, many labora-
tories are now actively working on the function of NLR in innate 
immunity of the UTI patients. It is essential to understand which 
inflammasomes play a critical role in UTIs and STIs; what their 
activation mechanisms are; and how these multiprotein complexes 
sense a wide array of alterations in a cell type-specific manner. 
This knowledge will potentially lead to an improved therapeutic 
and diagnostic approach for treating a range of infections.
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